Illumina Inc ILMN:NASDAQ

RT Quote | NASDAQ | USD
Last | 03/01/21 EST
446.50quote price arrow up+7.09 (+1.61%)
Volume
835,871
52 week range
196.78 - 555.77

...

Loading . . .

KEY STATS

  • Open449.00
  • Day High451.74
  • Day Low443.14
  • Prev Close446.50
  • 52 Week High555.77
  • 52 Week High Date02/12/21
  • 52 Week Low196.78
  • 52 Week Low Date03/18/20
  • Market Cap65.144B
  • Shares Out145.90M
  • 10 Day Average Volume1.14M
  • Dividend-
  • Dividend Yield-
  • Beta1.02
  • 1 Year % Change68.07

RATIOS/PROFITABILITY

  • EPS (TTM)4.43
  • P/E (TTM)100.74
  • Fwd P/E (NTM)90.83
  • EBITDA (MRQ)767.00M
  • ROE (MRQ)14.10%
  • Revenue (MRQ)3.239B
  • Gross Margin (MRQ)68.01%
  • Net Margin (MRQ)20.25%
  • Debt To Equity (MRQ)25.22%

EVENTS

  • Earnings Date04/28/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest ILMN News From Our Partners

QUOTE FINDER

Related Video

VIDEO3:2003:20
Illumina CEO on the hunt to find Covid-19 variants

Profile

MORE
Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc. (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations. Core Illumina's products and services serve customers in the research, clinical and applied markets, and enable the adoption of a...
Jay Flatley
Chairman
Francis deSouza
President
Sam Samad
Chief Financial Officer
Address
5200 Illumina Way
San Diego, CA
92122-4616
United States